Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Small Airway Involvement in Chronic Hypersensitivity Pneumonitis
NCT02523833Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Sep 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of salbutamol in chronic hypersensitivity pneumonitis (cHP), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Forced Expiratory Volume in 1 Second / Forced Vital Capacity Ratio at 1 day, Residual Volume at 1 day and 1 more. Started Sep 2015; status: completed.
02
Drugs
salbutamol
03
Conditions
chronic hypersensitivity pneumonitis (cHP)
Beyond the preview
Go deeper on NCT02523833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02523833.